The Business of Bioscience: What goes into making a Biotechnology ProductMy journey into this fascinating field of biotechnology started about 26 years ago at a small biotechnology company in South San Francisco called Genentech. I was very fortunate to work for the company that begat the biotech industry during its formative years. This experience established a solid foundation from which I could grow in both the science and business of biotechnology. After my fourth year of working on Oyster Point Boulevard, a close friend and colleague left Genentech to join a start-up biotechnology company. Later, he approached me to leave and join him in of all places – Oklahoma. He persisted for at least a year before I seriously considered his proposal. After listening to their plans, the opportunity suddenly became more and more intriguing. Finally, I took the plunge and joined this ent- preneurial team in cofounding and growing a start-up biotechnology company. Making that fateful decision to leave the security of a larger company was extremely difficult, but it turned out to be the beginning of an entrepreneurial career that forever changed how I viewed the biotechnology industry. Since that time, I have been fortunate to have cofounded two other biotechnology com- nies and even participated in taking one of them public. During my career in these start-ups, I held a variety of positions, from directing the science, operations, regulatory, and marketing components, to subsequently becoming CEO. |
Other editions - View all
The Business of Bioscience: What goes into making a Biotechnology Product Craig D. Shimasaki No preview available - 2009 |
The Business of Bioscience: What goes into making a Biotechnology Product Craig D. Shimasaki No preview available - 2014 |
Common terms and phrases
amount of capital Angel investors application approval biologic biotech company biotech entrepreneur biotech industry biotech product biotechnology company Biotechnology Product business model Business of Bioscience business plan businessperson challenges Chapter clinical testing clinical trials company's core values corporate attorney costs customers decisions development milestones development stage diagnostic discussed disease drug-eluting stent employees expertise filing financing founders funding future Genentech goals grants hire individuals institution interest investment issues leader license market need market research market strategy medical device opportunity organization partner partnerships patent patent prosecution pharmaceutical Phase potential problems product development raise capital raise money reach regulatory relationship responsibility restricted stock risk round of capital scientific scientists securities shareholders shares significant start-up company stock options successful target market therapeutic tion understand usually vaccine valuation Venture Capital